ArticleJournal of neuromuscular diseases2026
The FAIR journey of a patient-driven registry: Reflections and practical solutions from the Duchenne Data Platform FAIRification experience.
Article in Journal of neuromuscular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundSince 2018, World Duchenne Organization, Dutch Duchenne Parent Project, and Duchenne Data Foundation have been championing efforts to make Duchenne-related data reusable in combination with data contained in other registries. Transforming human language into a coded language that machines can understand ("FAIRification"; FAIR, Findable, Accessible, Interoperable, Reusable) offers a solution.PurposeTo recount and reflect on the process and challenges encountered during the FAIRification of a patient-registry, the Duchenne Data Platform.MethodsThe FAIRification plan was developed by a multidisciplinary team that was coordinated by a FAIR project manager. It focused on FAIRifying common data elements for rare disease registrations and patient-related outcome data. Protecting patient privacy and autonomy were at the forefront throughout the process. FAIR data transformation was accomplished through a combination of open-source and custom-written software. Data access for federated exploration was enabled through a privacy-preserving "data-visiting" approach.ResultsThe plan consisted of 10 main steps and addressed social, legal, ethical, and technical issues. Proof-of-concept testing for interoperability between the Duchenne Data Platform and four other registries demonstrated that FAIR data discovery and reuse was possible. Misconceptions about FAIR data persist, which act as barriers to scaling-up community-level FAIR efforts. Suggestions for overcoming these barriers are provided.ConclusionsData visiting and federated analyses between registries is possible. Actions to help mitigate hesitation to implement FAIR in practice include seeking out existing FAIR training opportunities, addressing misconceptions as needed, contacting FAIR experts for advice and using the open-source resources that we have shared.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.